Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s partners DST, UoH to develop anti-psoriatic drugs

Date: 24-05-2017

Dr. Reddy’s Laboratories (DRL) has joined hands with the Department of Science and Technology (DST) and University of Hyderabad (UoH) to initiate a project on discovery and development of anti-psoriatic drugs. The three entities have inked an agreement for the same. The venture, valued at Rs 1.90 crore, has been sponsored by DST and DRL.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.